Peer Exchange

Advances in Early Treatment Approaches in Multiple Sclerosis

EPISODE 1 : Updated McDonald Criteria for Diagnosing MS

Fred D. Lublin, MD leads a discussion on the 2017 revisions to the McDonald criteria to diagnose multiple sclerosis.

EPISODE 2 : Diagnostic Work-Up for MS

Key opinion leaders discuss red flags in making a multiple sclerosis diagnosis and the possibility for misdiagnosis.

EPISODE 3 : MRI in the Diagnosis of MS

Expert neurologists outline how the use of MRI has changed the diagnosis of multiple sclerosis and the importance of standardized protocols.

EPISODE 4 : Clinical Courses in MS

Fred D. Lublin, MD, outlines the 4 clinical courses in multiple sclerosis and that they must be framed in time.

EPISODE 5 : Modern Conversion Rate to Secondary MS

The decrease of the modern conversion rate to secondary progressive disease is discussed as well as the importance of a wellness program.

EPISODE 6 : Importance of Early Treatment of MS

Panelists discuss the importance and value of early identification and treatment of multiple sclerosis.

EPISODE 7 : Choosing Initial Therapy for Treatment of MS

Key opinion leaders agree there is no consensus on choosing initial therapy for treatment of multiple sclerosis.

EPISODE 8 : Factors to Consider for First-Line Therapy for MS

Panelists agree there is no treatment algorithm when starting therapy for multiple sclerosis but discuss some factors to consider when choosing therapy.

EPISODE 9 : Recent Treatment Strategies Explored for Relapsing MS

Implications for using cladribine or diroximel fumarate as therapy for relapsing multiple sclerosis, as well as considerations for selecting an appropriate dose of fingolimod.

EPISODE 10 : ASSESS Clinical Trial of Fingolimod for Treatment of MS

Stephen C. Krieger, MD, outlines the ASSESS clinical trial of the orally administered S1P receptor modulator fingolimod.